Company research
Praxis Precision Medicines, Inc.
CIK 1689548Updated Nov 13, 2026
SecurityPRAX · NASDAQ · equity
PRAX price & chart
Loading TradingView…
NASDAQ:PRAX on TradingView ↗In the news
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ↗
Recent filings
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
SCHEDULE 13G/A - filed by FMR LLC regarding Praxis Precision Medicines, Inc.
10-Q filing
Show 5 more recent filings
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Other Events
Items 8.01
Changes in Registrant's Certifying Accountant
Items 4.01, 9.01
Other Events
Items 8.01
144 filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 396,388,000Source | 416,256,000Source | 1,390,102,000Source | 452,832,000Source | 441,063,000Source | 1,460,202,000Source | 478,736,000Source | 250,409,000Source | 937,907,000Source | 483,110,000Source | 87,948,000Source | 115,128,000Source |
| Property, Plant and Equipment, NetUSD | 174,000Source | 277,000Source | 492,000Source | 258,000Source | 369,000Source | 170,000Source | 247,000Source | 476,000Source | 147,000Source | 230,000Source | 588,000Source | 971,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 149,527,000Source | 168,645,000Source | 474,761,000Source | 157,415,000Source | 145,143,000Source | 536,333,000Source | 165,567,000Source | 151,980,000Source | 357,329,000Source | 215,372,000Source | 81,300,000Source | 61,615,000Source |
| Assets, CurrentUSD | 273,844,000Source | 360,048,000Source | 771,903,000Source | 306,579,000Source | 356,716,000Source | 797,774,000Source | 333,575,000Source | 211,804,000Source | 610,911,000Source | 404,372,000Source | 84,880,000Source | 110,840,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 6,687,000Source | 3,016,000Source | 13,352,000Source | 5,304,000Source | 4,837,000Source | 10,909,000Source | 5,584,000Source | 4,388,000Source | 11,580,000Source | 11,805,000Source | 3,580,000Source | 10,351,000Source |
| Operating Lease, Right-of-Use AssetUSD | 362,000Source | 1,374,000Source | 1,001,000Source | 626,000Source | 1,610,000Source | 1,400,000Source | 882,000Source | 1,840,000Source | 92,000Source | 1,131,000Source | 2,064,000Source | 2,901,000Source |
| Other Assets, NoncurrentUSD | 0Source | 416,000Source | 643,000Source | 0Source | 416,000Source | — | 0Source | 416,000Source | 0Source | 416,000Source | 416,000Source | 416,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 52,883,000Source | 33,590,000Source | 49,058,000Source | 48,608,000Source | 21,963,000Source | 50,241,000Source | 39,522,000Source | 20,726,000Source | 59,771,000Source | 37,660,000Source | 18,279,000Source | 39,022,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 14,000Source | 14,000Source | 15,000Source | 14,000Source | 14,000Source | 15,000Source | 14,000Source | 13,000Source | 15,000Source | 14,000Source | 13,000Source | 5,000Source |
| Additional Paid in CapitalUSD | 1,394,088,000Source | 1,159,382,000Source | 2,659,990,000Source | 1,380,978,000Source | 1,145,308,000Source | 2,644,109,000Source | 1,344,577,000Source | 923,141,000Source | 2,017,566,000Source | 1,281,522,000Source | 723,577,000Source | 606,918,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,051,097,000Source | -778,061,000Source | -1,316,289,000Source | -977,163,000Source | -726,151,000Source | -1,232,569,000Source | -906,036,000Source | -693,474,000Source | -1,140,008,000Source | -836,740,000Source | -653,921,000Source | -530,644,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 500,000Source | 1,331,000Source | -2,672,000Source | 395,000Source | -71,000Source | -1,594,000Source | 659,000Source | 3,000Source | 563,000Source | 654,000Source | 0Source | -173,000Source |
| Stockholders' Equity Attributable to ParentUSD | 343,505,000Source | 382,666,000Source | 1,341,044,000Source | 404,224,000Source | 419,100,000Source | 1,409,961,000Source | 439,214,000Source | 229,683,000Source | 878,136,000Source | 445,450,000Source | 69,669,000Source | 76,106,000Source |
| Liabilities and EquityUSD | 396,388,000Source | 416,256,000Source | 1,390,102,000Source | 452,832,000Source | 441,063,000Source | 1,460,202,000Source | 478,736,000Source | 250,409,000Source | 937,907,000Source | 483,110,000Source | 87,948,000Source | 115,128,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 52,883,000Source | 32,861,000Source | 49,058,000Source | 48,608,000Source | 20,620,000Source | 50,241,000Source | 39,522,000Source | 18,794,000Source | 59,771,000Source | 37,550,000Source | 15,749,000Source | 34,345,000Source |
| Operating Lease, Liability, CurrentUSD | 436,000Source | 1,224,000Source | 1,087,000Source | 755,000Source | 1,191,000Source | 1,435,000Source | 1,066,000Source | 1,158,000Source | 110,000Source | 1,259,000Source | 1,126,000Source | 1,005,000Source |
| Accounts Payable, CurrentUSD | 30,819,000Source | 15,010,000Source | 23,386,000Source | 28,832,000Source | 8,195,000Source | 31,158,000Source | 22,909,000Source | 9,404,000Source | 24,628,000Source | 12,528,000Source | 5,815,000Source | 14,672,000Source |
| Operating Lease, Liability, NoncurrentUSD | 0Source | 436,000Source | — | 0Source | 755,000Source | — | 0Source | 1,066,000Source | 0Source | 110,000Source | 1,369,000Source | 2,495,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 21,628,000Source | 15,457,000Source | 24,585,000Source | 19,021,000Source | 10,058,000Source | 17,648,000Source | 15,547,000Source | 6,976,000Source | 35,033,000Source | 23,763,000Source | 7,416,000Source | 15,850,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 389,200,000Source | 411,200,000Source | 1,400,000,000Source | 446,600,000Source | 433,800,000Source | 1,400,000,000Source | 472,000,000Source | 243,300,000Source | 926,100,000Source | 469,500,000Source | 81,300,000Source | — |
| Intangible Assets, Net (Excluding Goodwill) | — | — | —Source | — | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 17,112,000Source | 8,786,000Source | 33,941,000Source | 41,360,000Source | 24,857,000Source | 28,593,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 6,530,000Source | 10,381,000Source | 12,097,000Source | 6,713,000Source | -8,855,000Source | 3,892,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -86,152,000Source | -53,010,000Source | -249,068,000Source | -131,757,000Source | -111,136,000Source | -185,043,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -344,275,000Source | -51,064,000Source | -311,148,000Source | -248,494,000Source | 38,950,000Source | 96,889,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 62,000Source | 0Source | 56,000Source | 0Source | 50,000Source | 444,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 12,923,000Source | 1,195,000Source | 2,089,000Source | 308,000Source | 137,000Source | 260,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 609,431,000Source | 54,269,000Source | 702,173,000Source | 514,323,000Source | 91,871,000Source | 10,465,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 179,004,000Source | -49,805,000Source | 141,957,000Source | 134,072,000Source | 19,685,000Source | -77,689,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 149,943,000Source | 169,061,000Source | 474,761,000Source | 157,831,000Source | 536,749,000Source | 165,983,000Source | 357,745,000Source | 215,788,000Source | 81,716,000Source | 62,031,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 224,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 7,447,000Source | 12,432,000Source | 11,309,000Source | 7,770,000Source | 17,112,000Source | 8,786,000Source | 33,941,000Source | 41,360,000Source | 24,857,000Source | 28,593,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 389,200,000Source | 411,200,000Source | 1,400,000,000Source | 446,600,000Source | 1,400,000,000Source | 472,000,000Source | 926,100,000Source | 469,500,000Source | 81,300,000Source | — |
| DepreciationUSD | — | — | — | — | — | — | 39,000Source | 47,000Source | 140,000Source | 358,000Source | 432,000Source | 419,000Source |
| Gain (Loss) on InvestmentsUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — | — |
| General and Administrative ExpenseUSD | — | — | 12,562,000Source | 15,256,000Source | 27,488,000Source | 13,061,000Source | 27,873,000Source | 13,922,000Source | 59,083,000Source | 56,305,000Source | 42,054,000Source | 59,946,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 471,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -73,934,000Source | -51,910,000Source | -83,720,000Source | -71,127,000Source | -92,561,000Source | -69,296,000Source | -303,268,000Source | -182,819,000Source | -123,277,000Source | -214,029,000Source |
| Nonoperating Income (Expense)USD | — | — | 4,425,000Source | 4,925,000Source | 13,184,000Source | 4,940,000Source | 13,299,000Source | 5,432,000Source | 22,930,000Source | 17,346,000Source | 3,096,000Source | 957,000Source |
| Operating ExpensesUSD | — | — | 78,359,000Source | 57,137,000Source | 96,904,000Source | 76,067,000Source | 105,860,000Source | 74,728,000Source | 326,198,000Source | 208,718,000Source | 128,820,000Source | 214,986,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 4,425,000Source | 4,925,000Source | 13,184,000Source | 4,940,000Source | 13,299,000Source | 5,432,000Source | 22,930,000Source | 17,346,000Source | 3,096,000Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 1,119,000Source | 560,000Source | — | — | — | 1,426,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 0Source | 302,000Source | — | 0Source | — | 0Source | 0Source | 8,553,000Source | 2,447,000Source | — |
| Operating Income (Loss)USD | — | — | -78,359,000Source | -56,835,000Source | -96,904,000Source | -76,067,000Source | -105,860,000Source | -74,728,000Source | -326,198,000Source | -200,165,000Source | -126,373,000Source | -214,986,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 4,425,000Source | 4,925,000Source | 13,184,000Source | 4,940,000Source | 13,299,000Source | 5,432,000Source | 22,930,000Source | 17,346,000Source | 3,096,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -302,797,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 471,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -73,934,000Source | -51,910,000Source | -83,720,000Source | -71,127,000Source | -92,561,000Source | -69,296,000Source | -303,268,000Source | -182,819,000Source | -123,277,000Source | -214,029,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -3.36Source | -2.75Source | -2.87Source | -3.31Source | -3.2Source | -3.29Source | -13.48Source | -10.21Source | -18.69Source | -4.64Source |
| Earnings Per Share, DilutedUSD per share | — | — | -3.36Source | -2.75Source | -2.87Source | -3.31Source | -3.2Source | -3.29Source | -13.48Source | -10.21Source | -18.69Source | -4.64Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 21,977,268Source | 18,884,562Source | 29,131,375Source | 21,474,827Source | 28,883,596Source | 21,055,834Source | 22,504,676Source | 17,906,794Source | 6,594,316Source | 46,096,737Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 21,977,268Source | 18,884,562Source | 29,131,375Source | 21,474,827Source | 28,883,596Source | 21,055,834Source | 22,504,676Source | 17,906,794Source | 6,594,316Source | 46,096,737Source |
| Additional Financial Items | ||||||||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 471,000Source | — | — | — |
| Gain (Loss) on InvestmentsUSD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — | — |
| General and Administrative ExpenseUSD | — | — | 12,562,000Source | 15,256,000Source | 27,488,000Source | 13,061,000Source | 27,873,000Source | 13,922,000Source | 59,083,000Source | 56,305,000Source | 42,054,000Source | 59,946,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -302,839,000Source | — | — | — |
| Interest Income, OtherUSD | — | — | — | — | — | — | — | — | — | — | — | 957,000Source |
| Nonoperating Income (Expense)USD | — | — | 4,425,000Source | 4,925,000Source | 13,184,000Source | 4,940,000Source | 13,299,000Source | 5,432,000Source | 22,930,000Source | 17,346,000Source | 3,096,000Source | 957,000Source |
| Operating ExpensesUSD | — | — | 78,359,000Source | 57,137,000Source | 96,904,000Source | 76,067,000Source | 105,860,000Source | 74,728,000Source | 326,198,000Source | 208,718,000Source | 128,820,000Source | 214,986,000Source |
| Research and Development ExpenseUSD | — | — | 65,797,000Source | 41,881,000Source | 69,416,000Source | 63,006,000Source | 77,987,000Source | 60,806,000Source | 267,115,000Source | 152,413,000Source | 86,766,000Source | 155,040,000Source |
| Restructuring and Related Cost, Incurred CostUSD | — | — | — | — | — | — | — | — | — | — | — | 1,000,000Source |
Filing attachments
tm2614259d1_ex99-1.htm · SCHEDULE 13G · 2026-05-15
EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that this Statement on Schedule 13G relating to the Common Stock of Praxis Precision Medicines, Inc. is being filed with the Securities and Exchange Commission on behalf of each of them. May 15, 2026 BAKER BROS. ADVISORS LP By: Baker Bros. Advisors (GP) LLC, its general partner By: /s/ Scott L. …
Read attachment ↗tm2528989d1_ex4-1.htm · 8-K · 2025-10-20
EX-4.1 3 tm2528989d1_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 PRAXIS PRECISION MEDICINES, INC. FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK Number of Shares: [ ] (subject to adjustment) Warrant No. [ ] Original Issue Date: October 20, 2025 Praxis Precision Medicines, Inc., a Delaware corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [ ] or its registered assigns (the “Holder”), is entit…
Read attachment ↗